中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

慢加急性肝衰竭的预后评价

张倩 韩涛

引用本文:
Citation:

慢加急性肝衰竭的预后评价

DOI: 10.3969/j.issn.1001-5256.2023.10.006
利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:张倩撰写论文;韩涛负责拟定写作思路,指导文章撰写。
详细信息
    通信作者:

    韩涛, hantaomd@126.com (ORCID: 0000-0003-4216-6968)

Prognostic evaluation of acute-on-chronic liver failure

More Information
    Corresponding author: HAN Tao, hantaomd@126.com (ORCID: 0000-0003-4216-6968)
  • 摘要: 慢加急性肝衰竭(ACLF)是临床常见的严重肝病临床症候群,短期病死率高。因此,早期准确评估ACLF患者预后,对临床决策及改善患者预后具有十分重要的意义。本文就近年来ACLF预后评价标志物的研究进展进行综述,旨在完善现有的预后评价体系,帮助临床医生及时给予适当的临床干预措施,进而降低患者病死率。

     

  • [1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.

    中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
    [2] SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific association for the study of the liver(APASL): An update[J]. Hepatol Int, 2019, 13( 4): 353- 390. DOI: 10.1007/s12072-019-09946-3.
    [3] MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144( 7): 1426- 1437, 1437.e1-1437.e9. DOI: 10.1053/j.gastro.2013.02.042.
    [4] BAJAJ JS, O’LEARY JG, REDDY KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures[J]. Hepatology, 2014, 60( 1): 250- 256. DOI: 10.1002/hep.27077.
    [5] JALAN R, YURDAYDIN C, BAJAJ JS, et al. Toward an improved definition of acute-on-chronic liver failure[J]. Gastroenterology, 2014, 147( 1): 4- 10. DOI: 10.1053/j.gastro.2014.05.005.
    [6] BAJAJ JS, O’LEARY JG, LAI JC, et al. Acute-on-chronic liver failure clinical guidelines[J]. Am J Gastroenterol, 2022, 117( 2): 225- 252. DOI: 10.14309/ajg.0000000000001595.
    [7] QI TT, ZHU CY, LU GT, et al. Elevated D-dimer is associated with increased 28-day mortality in acute-on-chronic liver failure in China: A retrospective study[J]. BMC Gastroenterol, 2019, 19( 1): 20. DOI: 10.1186/s12876-019-0941-0.
    [8] DONG SY, SUN CY, QIAO FF, et al. Value of age and D-dimer combined with Model for End-Stage Liver Disease in predicting the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2022, 38( 11): 2478- 2482. DOI: 10.3969/j.issn.1001-5256.2022.11.008.

    董少雨, 孙长宇, 乔芳芳, 等. 年龄和D-二聚体联合终末期肝病模型对HBV相关慢加急性肝衰竭患者预后的预测价值[J]. 临床肝胆病杂志, 2022, 38( 11): 2478- 2482. DOI: 10.3969/j.issn.1001-5256.2022.11.008.
    [9] KIM WR, MANNALITHARA A, HEIMBACH JK, et al. MELD 3.0: The model for end-stage liver disease updated for the modern era[J]. Gastroenterology, 2021, 161( 6): 1887- 1895.e 4. DOI: 10.1053/j.gastro.2021.08.050.
    [10] JALAN R, SALIBA F, PAVESI M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure[J]. J Hepatol, 2014, 61( 5): 1038- 1047. DOI: 10.1016/j.jhep.2014.06.012.
    [11] VERMA N, CHOUDHURY A, SINGH V, et al. APASL-ACLF Research Consortium-Artificial Intelligence(AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patients[J]. Liver Int, 2023, 43( 2): 442- 451. DOI: 10.1111/liv.15361.
    [12] WU TZ, LI J, SHAO L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. Gut, 2018, 67( 12): 2181- 2191. DOI: 10.1136/gutjnl-2017-314641.
    [13] LI JQ, LIANG X, YOU SL, et al. Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. J Hepatol, 2021, 75( 5): 1104- 1115. DOI: 10.1016/j.jhep.2021.05.026.
    [14] CHEN T, YANG ZY, CHOUDHURY AK, et al. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: A multi-national study from the Asia-Pacific region[J]. Hepatol Int, 2019, 13( 6): 695- 705. DOI: 10.1007/s12072-019-09992-x.
    [15] ZHANG ZW, YANG ZY, CHENG QY, et al. Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection[J]. Hepatol Int, 2022, 16( 1): 38- 47. DOI: 10.1007/s12072-021-10268-6.
    [16] XU MM, KONG M, YU PF, et al. Clinical course and outcome patterns of acute-on-chronic liver failure: A multicenter retrospective cohort study[J]. J Clin Transl Hepatol, 2021, 9( 5): 626- 634. DOI: 10.14218/JCTH.2020.00179.
    [17] YU ZJ, ZHANG Y, CAO YY, et al. A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators[J]. Sci Rep, 2021, 11( 1): 1810. DOI: 10.1038/s41598-021-81431-0.
    [18] YU ZJ, ZHANG Y, LI YH, et al. Development of a widely applicable and simple prognostic score for patients with acute-on-chronic liver failure[J]. J Clin Transl Hepatol, 2022, 10( 5): 867- 878. DOI: 10.14218/JCTH.2021.00328.
    [19] LI TP, GUAN SH, WANG Q, et al. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. World J Gastroenterol, 2019, 25( 37): 5667- 5675. DOI: 10.3748/wjg.v25.i37.5667.
    [20] GRØNBAEK H, MØLLER HJ, SALIBA F, et al. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation[J]. J Gastroenterol Hepatol, 2021, 36( 1): 240- 248. DOI: 10.1111/jgh.15125.
    [21] von MEIJENFELDT FA, STRAVITZ RT, ZHANG JW, et al. Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome[J]. Hepatology, 2022, 75( 3): 623- 633. DOI: 10.1002/hep.32174.
    [22] BLASI A, PATEL VC, ADELMEIJER J, et al. Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF[J]. JHEP Rep, 2019, 1( 3): 179- 187. DOI: 10.1016/j.jhepr.2019.06.002.
    [23] ZHANG IW, CURTO A, LÓPEZ-VICARIO C, et al. Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure[J]. J Hepatol, 2022, 76( 1): 93- 106. DOI: 10.1016/j.jhep.2021.08.009.
    [24] LIU Y, MENG X, WANG C, et al. Interleukin-18 plays a positive feedback activity to natural killer-like B cells in hepatitis B virus-associated acute-on-chronic liver failure[J]. Viral Immunol, 2022, 35( 1): 50- 59. DOI: 10.1089/vim.2021.0164.
    [25] MOREAU R, GAO B, PAPP M, et al. Acute-on-chronic liver failure: A distinct clinical syndrome[J]. J Hepatol, 2021, 75( Suppl 1): S27-S35. DOI: 10.1016/j.jhep.2020.11.047.
    [26] HUANG ZX, WANG N, HUANG SW, et al. Increased serum soluble urokinase plasminogen activator receptor predicts short-term outcome in patients with hepatitis B-related acute-on-chronic liver failure[J]. Gastroenterol Res Pract, 2019, 2019: 3467690. DOI: 10.1155/2019/3467690.
    [27] ZHANG XY, DONG PL, XU L, et al. The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure[J]. BMC Gastroenterol, 2019, 19( 1): 148. DOI: 10.1186/s12876-019-1064-3.
    [28] LIU H, HAN T, TIAN J, et al. Monitoring oxidative stress in acute-on-chronic liver failure by advanced oxidation protein products[J]. Hepatol Res, 2012, 42( 2): 171- 180. DOI: 10.1111/j.1872-034X.2011.00911.x.
    [29] CAI JJ, HAN T, NIE CY, et al. Biomarkers of oxidation stress, inflammation, necrosis and apoptosis are associated with hepatitis B-related acute-on-chronic liver failure[J]. Clin Res Hepatol Gastroenterol, 2016, 40( 1): 41- 50. DOI: 10.1016/j.clinre.2015.06.009.
    [30] JUANOLA A, GRAUPERA I, ELIA C, et al. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis[J]. J Hepatol, 2022, 76( 1): 107- 114. DOI: 10.1016/j.jhep.2021.08.031.
    [31] HUANG GQ, XIE YY, ZHU PW, et al. Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure[J]. Expert Rev Gastroenterol Hepatol, 2018, 12( 3): 295- 302. DOI: 10.1080/17474124.2018.1424540.
    [32] JIAO Y, LU W, XU P, et al. Hepatocyte-derived exosome may be as a biomarker of liver regeneration and prognostic valuation in patients with acute-on-chronic liver failure[J]. Hepatol Int, 2021, 15( 4): 957- 969. DOI: 10.1007/s12072-021-10217-3.
    [33] TAO YC, WANG ML, WANG M, et al. Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure[J]. Dig Liver Dis, 2019, 51( 3): 412- 418. DOI: 10.1016/j.dld.2018.08.030.
    [34] CISILOTTO J, AMARAL AE DO, ROSOLEN D, et al. microRNA profiles in serum samples from acute-on-chronic liver failure patients and miR-25-3p as a potential biomarker for survival prediction[J]. Sci Rep, 2020, 10( 1): 100. DOI: 10.1038/s41598-019-56630-5.
    [35] MA SS, XIE ZY, ZHANG LJ, et al. Identification of a potential miRNA-mRNA regulatory network associated with the prognosis of HBV-ACLF[J]. Front Mol Biosci, 2021, 8: 657631. DOI: 10.3389/fmolb.2021.657631.
    [36] GAO S, FAN YC, HAN LY, et al. Serum exosomal long noncoding RNA nuclear-enriched abundant transcript 1 predicts 90-day mortality in acute-on-chronic hepatitis B liver failure[J]. Expert Rev Clin Immunol, 2021, 17( 7): 789- 797. DOI: 10.1080/1744666X.2021.1933442.
    [37] SHAO S, ZHANG Y, ZHOU F, et al. LncRNA-Airn alleviates acute liver injury by inhibiting hepatocyte apoptosis via the NF-κB signaling pathway[J]. Acta Biochim Biophys Sin, 2022, 54( 11): 1619- 1629. DOI: 10.3724/abbs.2022167.
    [38] WEI LL, WANG T, CHEN SS, et al. Serum anti-fumarate hydratase autoantibody as a biomarker for predicting prognosis of acute-on-chronic liver failure[J]. Gut Liver, 2022. DOI: 10.5009/gnl220022.[ Online ahead of print]
    [39] NIE CY, HAN T, ZHANG L, et al. Cross-sectional and dynamic change of serum metabolite profiling for Hepatitis B-related acute-on-chronic liver failure by UPLC/MS[J]. J Viral Hepat, 2014, 21( 1): 53- 63. DOI: 10.1111/jvh.12122.
    [40] CLÀRIA J, MOREAU R, FENAILLE F, et al. Orchestration of tryptophan-kynurenine pathway, acute decompensation, and acute-on-chronic liver failure in cirrhosis[J]. Hepatology, 2019, 69( 4): 1686- 1701. DOI: 10.1002/hep.30363.
    [41] TROVATO FM, ZIA R, NAPOLI S, et al. Dysregulation of the lysophosphatidylcholine/autotaxin/lysophosphatidic acid axis in acute-on-chronic liver failure is associated with mortality and systemic inflammation by lysophosphatidic acid-dependent monocyte activation[J]. Hepatology, 2021, 74( 2): 907- 925. DOI: 10.1002/hep.31738.
    [42] SOLÉ C, GUILLY S, SILVA KD, et al. Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics: Relationship with acute-on-chronic liver failure and prognosis[J]. Gastroenterology, 2021, 160( 1): 206- 218.e 13. DOI: 10.1053/j.gastro.2020.08.054.
    [43] HU CH, JIANG N, ZHENG J, et al. Liver volume based prediction model for patients with hepatitis B virus-related acute-on-chronic liver failure[J]. J Hepatobiliary Pancreat Sci, 2022, 29( 12): 1253- 1263. DOI: 10.1002/jhbp.1112.
    [44] LIU CX, SHEN ZJ, MA H, et al. Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure[J]. Eur Radiol, 2022, 32( 5): 3006- 3015. DOI: 10.1007/s00330-021-08440-5.
    [45] JADAUN SS, SHARMA S, MADHUSUDHAN KS, et al. Spectrum of neuroimaging abnormalities in brain in patients of acute-on-chronic liver failure[J]. J Clin Exp Hepatol, 2022, 12( 2): 343- 352. DOI: 10.1016/j.jceh.2021.08.007.
    [46] VOGG J, MAIER-STOCKER C, MUNKER S, et al. Hepatic perfusion as a new predictor of prognosis and mortality in critical care patients with acute-on-chronic liver failure[J]. Front Med, 2022, 9: 1008450. DOI: 10.3389/fmed.2022.1008450.
    [47] GAO F, HUANG XL, CAI MX, et al. Prognostic value of serum lactate kinetics in critically ill patients with cirrhosis and acute-on-chronic liver failure: A multicenter study[J]. Aging, 2019, 11( 13): 4446- 4462. DOI: 10.18632/aging.102062.
    [48] ZHANG LJ, ZHAO YL, XIE ZY, et al. 1, 5-anhydroglucitol predicts mortality in patients with HBV-related acute-on-chronic liver failure[J]. J Clin Transl Hepatol, 2022, 10( 4): 651- 659. DOI: 10.14218/JCTH.2021.00347.
    [49] XIONG Y, XIA ZX, YANG L, et al. Low T3 syndrome is associated with poor prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Expert Rev Gastroenterol Hepatol, 2022, 16( 7): 681- 687. DOI: 10.1080/17474124.2022.2090336.
    [50] ZHANG J, CHEN Y, DING M, et al. Correlation between dynamic changes in free triiodothyronine levels and 90-day prognosis in patients with HBV-related acute-on-chronic liver failure[J]. Eur J Med Res, 2022, 27( 1): 88. DOI: 10.1186/s40001-022-00718-8.
  • 加载中
计量
  • 文章访问数:  379
  • HTML全文浏览量:  91
  • PDF下载量:  80
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-06-05
  • 出版日期:  2023-10-30
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回